Southwest Falls in Premarket; Meituan ADRs, Exxon Mobil Rise By Investing.com

© Reuters. By Geoffrey Smith Investing.com — Stocks in focus in premarket trading on Monday, 11th October. Please refresh for updates Southwest Airlines (NYSE:) stock fell 2.6% after a heavily disrupted weekend for flight movements, as bad weather in Florida led to cascading problems of aircraft and personnel availability. The […]


© Reuters.

By Geoffrey Smith

Investing.com — Stocks in focus in premarket trading on Monday, 11th October. Please refresh for updates

  • Southwest Airlines (NYSE:) stock fell 2.6% after a heavily disrupted weekend for flight movements, as bad weather in Florida led to cascading problems of aircraft and personnel availability. The airline canceled over 1,000 flights on Sunday, or more than a quarter of its schedule. 
  • Aspen Tech stock rose 4.2% after Emerson (NYSE:) Electric agreed to spin off its industrial software operations into the company in a deal aimed at creating a more full suite of services to large industrial customers. Emerson stock was unchanged, having traded down earlier in the premarket session
  • Hasbro (NASDAQ:) stock fell 1.3% after the company announced that CEO Brian Goldner will take medical leave, with immediate effect. Rich Stoddart, the company’s lead independent director, will take over the role of CEO on an interim basis. 
  • Meituan ADRs rose 4.7% to their highest in two and a half months after the company escaped largely unscathed from an antitrust probe. China’s competition watchdog fined it $534 million for various abuses of a dominant position in the food delivery market. Other Chinese ADRs rose in sympathy, on hopes that the worst case scenario envisaged by some under Beijing’s crackdown on tech companies can be avoided.
  • Exxon Mobil (NYSE:) stock rose 1.5% to a three-month high as crude oil prices continued their ascent. futures hit a fresh seven-year high as trading in New York began, still supported by a sharp squeeze on gas and coal markets worldwide. 
  • AstraZeneca (NASDAQ:) ADRs rose 0.6% after it reported promising trial results for an experimental antiviral drug for treating Covid-19. The company said the drug reduced the risk of serious illness by half in a trial a little larger than the one carried out by Merck (NYSE:)for a similar drug.
  • Merck stock rose 0.6% after the pharma company formally requested emergency use authorization for its antiviral Covid-19 pill, which could become the first effective orally-administered drug against the coronavirus.
  • KKR  (NYSE:) stock rose 0.8%, extending Friday’s gains as the private equity giant’s two remaining founders said they will step down and hand the reins to long-time company insiders.

 

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

Next Post

Fraying Relations With China Are About To Hit Australian Economy

Tue Oct 12 , 2021
Content Inside Business Is Economics A Science? August Jobs Report: Which Industries Hired The Most, Least Staff Last Month? Meski Baru, Berikut Hal Yang Harus Diketahui Dari Circular Financial System For Chinese firms that want to be globally aggressive and world class, restrictions on interaction with US companies are problematic. […]
Copyright All right reserved Theme: Default Mag by ThemeInWP